The prevalence and predictors of erectile dysfunction in men with newly diagnosed with type 2 diabetes mellitus

BJU International

Volumn 99, Issue 1, 2007, Pages 130-134

  Al Hunayan, Adel ^a   Al Mutar, Manal ^b   Kehinde, Elijah O ^a   Thalib, Lukman ^a   Al Ghorory, Mounir ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MINISTRY OF HEALTH   (Kuwait)

Author keywords

Complications; Diabetes mellitus; Erectile dysfunction; Prevalence; Risk factors

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; ERECTILE DYSFUNCTION; HUMAN; HYPERTENSION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

ADULT; AGE FACTORS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; IMPOTENCE, VASCULOGENIC; KUWAIT; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RISK FACTORS;

EID: 33845491526     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06550.x     Document Type: Article

References (30)

1. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241: 2035-8
2. De Vegt F, Dekker JM, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ. Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study. Diabetes Care 2000; 23: 40-4
3. Engelgau MM, Narayan KM, Herman WH. Screening for type 2 diabetes. Diabetes Care 2000; 23: 1563-80.
4. Kohner EM, Aldington SJ, Stratton IM et al. United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 1998; 116: 297-303
5. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992; 15: 815-9
6. Spijkerman AM, Henry RM, Dekker JM et al. Prevalence of macrovascular disease amongst type 2 diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn Screening Study. J Intern Med 2004; 256: 429-36
7. Melman A, Gingell JC. The epidemiology and pathophysiology of erectile dysfunction. J Urol 1999; 161: 5-11
8. De Berardis G, Franciosi M, Belfiglio M et al; The Quality of Care and Outcomes in Type 2 Diabetes (QuED) Study Group. Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked. Diabetes Care 2002; 25: 284-91
9. McCulloch DK, Campbell IW, Wu FC, Prescott RJ, Clarke BF. The prevalence of diabetic impotence. Diabetologia 1980; 18: 279-83
10. Rubin A, Babbott D. Impotence and diabetes mellitus. J Am Med Assoc 1958; 168: 498-500
11. Deutsch S, Sherman L. Previously unrecognized diabetes mellitus in sexually impotent men. JAMA 1980; 244: 2430-2
12. Yamasaki H, Ogawa K, Sasaki H et al. Prevalence and risk factors of erectile dysfunction in Japanese men with type 2 diabetes. Diabetes Res Clin Pract 2004; 66 (Suppl. 1): S173-7
13. Roth A, Kalter-Leibovici O, Kerbis Y et al. Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1412 Israeli men. Clin Cardiol 2003; 26: 25-30
14. Cavan DA, Barnett AH, Leatherdale BA. Diabetic impotence: risk factors in a clinic population. Diabetes Res 1987; 5: 145-8
15. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-97
16. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319-26
17. World Health Organization-International Society of Hypertension. Guidelines for the management of hypertension. Guidelines Subcommittee. J Hypertens 1999; 17: 151-83
18. Sairam K, Kulinskaya E, Boustead GB, Hanbury DC, McNicholas TA. Prevalence of undiagnosed diabetes mellitus in male erectile dysfunction. BJU Int 2001; 88: 68-71
19. Giuliano FA, Leriche A, Jaudinot EO, de Gendre AS. Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both. Urology 2004; 64: 1196-201
20. Nathan DM, Singer DE, Godine JE, Perlmuter LC. Non-insulin-dependent diabetes in older patients. Complications and risk factors. Am J Med 1986; 81: 837-42
21. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61
22. Klein R, Klein BE, Lee KE, Moss SE, Cruickshanks KJ. Prevalence of self-reported erectile dysfunction in people with long-term IDDM. Diabetes Care 1996; 19: 135-41
23. Brunner GA, Pieber TR, Schattemberg S et al. [Erectile dysfunction in patients with type I diabetes mellitus]. Wien Med Wochenschr 1995; 145: 584-6
24. Martin CE. Factors affecting sexual functioning in 60-79-year-old married males. Arch Sex Behav 1981; 10: 399-420
25. Fedele D, Coscelli C, Santeusanio F et al. Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. Diabetes Care 1998; 21: 1973-7
26. Virag R, Bouilly P, Frydman D. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985; 26: 181-4
27. Shabsigh R, Fishman IJ, Schum C, Dunn JK. Cigarette smoking and other vascular risk factors in vasculogenic impotence. Urology 1991; 38: 227-31
28. Muller SC, el-Damanhoury H, Ruth J, Luc TF. Hypertension and impotence. Eur Urol 1991; 19: 29-34
29. Fedele D, Coscelli C, Cucinotta D et al. Incidence of erectile dysfunction in Italian men with diabetes. J Urol 2001; 166: 1368-71
30. McCulloch DK, Young RJ, Prescott RJ, Campbell IW, Clarke BF. The natural history of impotence in diabetic men. Diabetologia 1984; 26: 437-40